PathogenDx
PrivateLast Round
Grant
Mar 1, 2021
Total Funding Raised
$12.56M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
PathogenDx is a biotechnology company that provides a DNA-based pathogen testing platform for the cannabis, agriculture, food, and human diagnostics industries.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Environmental Monitoring
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PathogenDx Comparables
Compare PathogenDx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TUMI Genomics | 71% | |
| MyFloraDNA, Inc. | 71% | |
| bioMérieux | 69% |
PathogenDx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 1, 2021 | ||||
| Grant | Jul 28, 2020 | ||||
| Series B | Sep 30, 2019 | ||||
| Convertible Debt | Jul 17, 2018 |
Key People
Founding team and executive leadership
PathogenDx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Biomedical Imaging and Bioengineering | Grant |
| Salveo Capital | Convertible Debt, Series B |
| U.S. Department of Health and Human Services | Grant |
| NIH RADx | Grant |
| Altitude Investment Management | Series B, Convertible Debt |
| Flatiron Venture Partners | Series B |
| Advance Ventures | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 123% MoM, reaching 17K.
- Jul 26, 2026
Monthly visitors increased 215% MoM, reaching 7.6K.
PathogenDx Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about PathogenDx's valuation, stock price, and market status.
Is PathogenDx a public or private company?
PathogenDx is a private company.
What is the current stock price of PathogenDx?
PathogenDx is a private company with no public stock price. No recent secondary market data is available.
How much is PathogenDx worth (valuation)?
Valuation information for PathogenDx is not publicly available.
Can I buy PathogenDx stock?
PathogenDx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was PathogenDx's last funding round?
PathogenDx's most recent funding round was Grant on March 1, 2021.
Who are the main investors in PathogenDx?
Key investors in PathogenDx include Altitude Investment Management, Entourage Effect Capital, The Panther Opportunity Fund.
Will PathogenDx IPO soon?
No public IPO plans have been announced for PathogenDx.
How can I track PathogenDx secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor PathogenDx's secondary market activity and sign up for updates.